glp 1 ra Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care GLP-1 and Anesthesia: Considerations and
Description
Although the cardioprotective effects of GLP-1RA are more established in atherosclerotic cardiovascular disease than in heart failure, recent studies demonstrate a modest but clinically meaningful benefit in heart failure with preserved ejection fraction (HFpEF), particularly among obese patients
This signaling reduces hunger, increases satiety, and decreases food intake
The change could also introduce a new administrative considerations for patients and providers as they evaluate alternatives or navigate exceptions
However, our current understanding of their full long-term implications remains incomplete
